ExodusPoint Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

ExodusPoint Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-83,247	Closed	-$1.5M	–	2297
2022 Q3	$1.5M	Buy	83,247 +13,341	+19%	+$213K	0.02%	933
2022 Q2	$869K	Buy	69,906 +48,192	+222%	+$532K	0.01%	1148
2022 Q1	$289K	Sell	21,714 -465	-2%	-$6.24K	﹤0.01%	1776
2021 Q4	$345K	Sell	22,179 -2,882	-11%	-$55K	﹤0.01%	1603
2021 Q3	$562K	Sell	25,061 -181,717	-88%	-$3.99M	0.01%	1311
2021 Q2	$4.71M	Buy	+206,778	New	+$4.35M	0.05%	380
2020 Q4	–	Sell	-40,424	Closed	-$568K	–	2510
2020 Q3	$568K	Sell	40,424 -3,098	-7%	-$57.6K	0.01%	947
2020 Q2	$897K	Buy	+43,522	New	+$592K	0.02%	797
2019 Q4	–	Sell	-12,600	Closed	-$66K	–	1990
2019 Q3	$66K	Buy	+12,600	New	+$93.5K	﹤0.01%	1264

Other funds holding MYOV

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ExodusPoint Capital Management's MYOV Position: Q4 2022 in Review

ExodusPoint Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 83,247 shares — an estimated $1.5M sold.

ExodusPoint Capital Management first reported a position in MYOV in Q3 2019 and held it in 9 quarters. The position peaked at $4.71M in Q2 2021. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

ExodusPoint Capital Management reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 83,247 Myovant Sciences Ltd. shares in Q4 2022, an estimated $1.5M.
ExodusPoint Capital Management first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 9 quarters.
ExodusPoint Capital Management's Myovant Sciences Ltd. position peaked at $4.71M in Q2 2021.
118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.